Recruiting Psoriatic Arthritis Studies in Gilbert
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
An open label phase 3 study...
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe PsA and obesity or overw...
About Psoriatic Arthritis Clinical Trials in Gilbert
Psoriatic arthritis is a form of inflammatory arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling. It can affect any joint and varies in severity. Treatment includes NSAIDs, DMARDs, biologics, and JAK inhibitors.
There are currently 2 psoriatic arthritis clinical trials recruiting participants in Gilbert, ARIZONA. These studies are seeking a combined 850 participants. Research is being sponsored by Sun Pharmaceutical Industries Limited, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Psoriatic Arthritis Clinical Trials in Gilbert — FAQ
Are there psoriatic arthritis clinical trials in Gilbert?
Yes, there are 2 psoriatic arthritis clinical trials currently recruiting in Gilbert, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Gilbert?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you about next steps.
Are clinical trials in Gilbert free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gilbert studies also compensate for your time and travel.
What psoriatic arthritis treatments are being tested?
The 2 active trials in Gilbert are testing new therapies including novel drugs, biologics, and treatment approaches for psoriatic arthritis.
Data updated March 2, 2026 from ClinicalTrials.gov